Delivery Order SPE2DB22D1041-SPE2DB24FTYM5
- Not listed
- This federal contract award is for the supply of DESCOVY 200-25 MG TABLET to the Defense Logistics Agency (DLA), a defense agency. The $1,999.68 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 5, 2025. The contract has an ultimate completion date of February 6, 2025 and was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of DESCOVY 200-25 MG TABLET, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $10,089.48 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 6, 2024, with a completion date of February 7, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide...
- This federal contract award is for the delivery of DESCOVY 200-25 MG TABLET medical products to the Defense Logistics Agency (DLA). The $19,602.64 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on October 22, 2024. The contract has an ultimate completion date of October 23, 2024 and does not have any set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of DESCOVY 200-25 MG TABLET UU 30S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $2,842.20 firm fixed-price delivery order contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of July 18, 2025 and was not set aside for any special designation. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award is for the delivery of DESCOVY 200-25 MG TABLET UU 30S to the Defense Logistics Agency (DLA). The $5,454.14 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 26, 2024 and is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of DESCOVY 200-25 MG TABLET to the Defense Logistics Agency (DLA). The $6,586.67 firm fixed-price delivery order has a completion date of January 22, 2024. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical...
- This federal contract award by the Defense Logistics Agency (DLA) is for the delivery of DESCOVY 200-25 MG TABLET medical products to support military healthcare programs. The $9,974.19 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 19, 2023 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,726.11 firm fixed-price delivery order is for the supply of DESCOVY 200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has a completion date of March 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award is for the delivery of DESCOVY 200-25 MG TABLET UU 30S to the Defense Logistics Agency (DLA). The firm fixed-price delivery order, valued at $49,044.65, has a completion date of June 24, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is not set aside and is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of DESCOVY 200-25 MG TABLET. The contract, valued at $12,837.86, is a firm fixed price delivery order with a completion date of January 24, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary...
- SPE2DB22D1041Indefinite Delivery Contract
- SPE2DB22D1041-SPE2DB24FTYM5Delivery Order
This federal contract award is for the delivery of DESCOVY 200-25 MG TABLET to the Defense Logistics Agency (DLA). The $13,642.90 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on November 21, 2023, with a completion date of November 22, 2023. The contract is not associated with a set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.6k | 11/21/23 |